Monalisa Valuation
Is A012690 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of A012690 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: A012690 (₩2790) is trading below our estimate of fair value (₩5296.61)
Significantly Below Fair Value: A012690 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for A012690?
Key metric: As A012690 is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.
| What is A012690's PB Ratio? | |
|---|---|
| PB Ratio | n/a |
| Book | ₩18.94b |
| Market Cap | ₩102.00b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does A012690's PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.4x | ||
A004540 KleanNara | 0.4x | n/a | ₩73.8b |
A065950 Welcron | 0.8x | n/a | ₩55.9b |
A018250 Aekyung Industrial | 0.9x | 18.1% | ₩358.5b |
A123690 Hankook Cosmetics | 3.5x | n/a | ₩99.5b |
A012690 Monalisa | n/a | n/a | ₩102.0b |
Price-To-Book vs Peers: Insufficient data to calculate A012690's Price-To-Book Ratio vs. peers for valuation analysis.
Price to Book Ratio vs Industry
How does A012690's PB Ratio compare vs other companies in the Asian Household Products Industry?
| 1 Company | Price / Book | Estimated Growth | Market Cap |
|---|---|---|---|
| 1 Company | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Book vs Industry: Insufficient data to calculate A012690's Price-To-Book Ratio vs. industry for valuation analysis.
Price to Book Ratio vs Fair Ratio
What is A012690's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | n/a |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate A012690's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
NeoPharm
₩181.1b
Engages in the manufacturing and sale of skin care products in South Korea.
A092730
₩11,580.00
7D
-11.4%
1Y
2.7%
NOVAREXLtd
₩135.1b
Manufactures, wholesales, and retails health and functional foods in South Korea and internationally.
A194700
₩7,630.00
7D
-4.9%
1Y
-30.8%
Cosmax
₩1.5t
Researches, develops, produces, and manufactures cosmetic and health function food products in Korea and internationally.
A192820
₩132,500.00
7D
-2.1%
1Y
15.5%